348 related articles for article (PubMed ID: 34402924)
1. Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Chen Q; Zhang L; Mo X; You J; Chen L; Fang J; Wang F; Jin Z; Zhang B; Zhang S
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):345-360. PubMed ID: 34402924
[TBL] [Abstract][Full Text] [Related]
2. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
[TBL] [Abstract][Full Text] [Related]
3. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
[TBL] [Abstract][Full Text] [Related]
4. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives.
Chetan MR; Gleeson FV
Eur Radiol; 2021 Feb; 31(2):1049-1058. PubMed ID: 32809167
[TBL] [Abstract][Full Text] [Related]
5. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
7. Current status and quality of radiomics studies for predicting outcome in acute ischemic stroke patients: a systematic review and meta-analysis.
Kong J; Zhang D
Front Neurol; 2023; 14():1335851. PubMed ID: 38229595
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer.
Tunali I; Tan Y; Gray JE; Katsoulakis E; Eschrich SA; Saller J; Aerts HJWL; Boyle T; Qi J; Guvenis A; Gillies RJ; Schabath MB
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34409252
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of radiomic biomarkers for predicting immune checkpoint inhibitor treatment outcomes.
Zhang C; de A F Fonseca L; Shi Z; Zhu C; Dekker A; Bermejo I; Wee L
Methods; 2021 Apr; 188():61-72. PubMed ID: 33271285
[TBL] [Abstract][Full Text] [Related]
10. Radiomics in precision medicine for gastric cancer: opportunities and challenges.
Chen Q; Zhang L; Liu S; You J; Chen L; Jin Z; Zhang S; Zhang B
Eur Radiol; 2022 Sep; 32(9):5852-5868. PubMed ID: 35316364
[TBL] [Abstract][Full Text] [Related]
11. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
12. The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.
Yang Z; Gong J; Li J; Sun H; Pan Y; Zhao L
Int J Surg; 2023 Aug; 109(8):2451-2466. PubMed ID: 37463039
[TBL] [Abstract][Full Text] [Related]
13. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
14. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis.
Jia LL; Zhao JX; Zhao LP; Tian JH; Huang G
Eur J Radiol; 2023 Jan; 158():110640. PubMed ID: 36525703
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer.
Felfli M; Liu Y; Zerka F; Voyton C; Thinnes A; Jacques S; Iannessi A; Bodard S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511192
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer.
Xu J; Wang P; Li Y; Shi X; Yin T; Yu J; Teng F
Front Immunol; 2024; 15():1373330. PubMed ID: 38686383
[TBL] [Abstract][Full Text] [Related]
17. Radiomics of
Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.
Wu S; Zhan W; Liu L; Xie D; Yao L; Yao H; Liao G; Huang L; Zhou Y; You P; Huang Z; Li Q; Xu B; Wang S; Wang G; Zhang DK; Qiao G; Chan LW; Lanuti M; Zhou H
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37865396
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis.
Meng G; Liu X; Ma T; Lv D; Sun G
PLoS One; 2022; 17(2):e0263629. PubMed ID: 35113949
[TBL] [Abstract][Full Text] [Related]
20. Post-radiotherapy stage III/IV non-small cell lung cancer radiomics research: a systematic review and comparison of CLEAR and RQS frameworks.
Tran K; Ginzburg D; Hong W; Attenberger U; Ko HS
Eur Radiol; 2024 Apr; ():. PubMed ID: 38625613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
